| 000 | 01902 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516103040.0 | ||
| 264 | 0 | _c20130723 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1916-7075 | ||
| 024 | 7 |
_a10.1016/j.cjca.2012.05.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFox, Benjamin | |
| 245 | 0 | 0 |
_aHemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension. _h[electronic resource] |
| 260 |
_bThe Canadian journal of cardiology _cJun 2013 |
||
| 300 |
_a672-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 | _aFamilial Primary Pulmonary Hypertension |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aIsoxazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhenylpropionates _xadministration & dosage |
| 650 | 0 | 4 |
_aPulmonary Wedge Pressure _xdrug effects |
| 650 | 0 | 4 |
_aPyridazines _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 700 | 1 | _aLangleben, David | |
| 700 | 1 | _aHirsch, Andrew M | |
| 700 | 1 | _aSchlesinger, Robert D | |
| 700 | 1 | _aEisenberg, Mark J | |
| 700 | 1 | _aJoyal, Dominique | |
| 700 | 1 | _aBlenkhorn, Fay | |
| 700 | 1 | _aLesenko, Lyda | |
| 773 | 0 |
_tThe Canadian journal of cardiology _gvol. 29 _gno. 6 _gp. 672-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cjca.2012.05.013 _zAvailable from publisher's website |
| 999 |
_c21963637 _d21963637 |
||